Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “COR Therapeutics, Inc.”

30 pharma patents match "COR Therapeutics, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 30
Index total 30,257
Page 2 / 2

Quick answer

This filtered view shows 30 pharmaceutical patents matching "COR Therapeutics, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

30 results for “COR Therapeutics, Inc.” · 30,257 patents in full index Clear search

  1. US 6063582

    Methods of screening for compounds that interact with human P.sub.2u2 purinergic receptor

    COR Therapeutics, Inc. · Granted May 16, 2000 · Expires May 11, 2020

    expired

  2. US 6063794

    Selective factor Xa inhibitors

    COR Therapeutics, Inc. · Granted May 16, 2000 · Expires May 11, 2020

    expired

  3. US 6060588

    Bap-1 proteins

    COR Therapeutics, Inc. · Granted May 9, 2000 · Expires May 4, 2020

    expired

  4. US 6046169

    Inhibitors of factor XA

    COR Therapeutics, Inc. · Granted Apr 4, 2000 · Expires Mar 30, 2020

    expired

  5. US 6043212

    Recombinant C140 receptor, its agonists and antagonists, and nucleic acids encoding the receptor

    COR Therapeutics, Inc. · Granted Mar 28, 2000 · Expires Mar 23, 2020

    expired

  6. US 6022861

    Ketoheterocyclic inhibitors of factor Xa

    COR Therapeutics, Inc. · Granted Feb 8, 2000 · Expires Feb 3, 2020

    expired

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.